Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DANENBERG, Kathleen D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 53

  • Page / 3
Export

Selection :

  • and

Both β-Actin and GAPDH are Useful Reference Genes for Normalization of Quantitative RT-PCR in Human FFPE Tissue Samples of Prostate CancerMORI, Ryutaro; QINGCAI WANG; DANENBERG, Kathleen D et al.The Prostate. 2008, Vol 68, Num 14, pp 1555-1560, issn 0270-4137, 6 p.Article

A Three-Gene Signature for Outcome in Soft Tissue SarcomaHOFFMAN, Andreas-Claudius; DANENBERG, Kathleen D; TAUBERT, Helge et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5191-5198, issn 1078-0432, 8 p.Article

Inhibition of pre-mRNA splicing by cisplatin and platinum analogsSCHMITTGEN, Thomas D; JU, Jing-Fang; DANENBERG, Kathleen D et al.International journal of oncology. 2003, Vol 23, Num 3, pp 785-789, issn 1019-6439, 5 p.Article

High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancerJOSHI, Mary-Beth Moore; SHIROTA, Yoshinori; DANENBERG, Kathleen D et al.Clinical cancer research. 2005, Vol 11, Num 6, pp 2215-2221, issn 1078-0432, 7 p.Article

Molecular determinants of cetuximab efficacyVALLBÖHMER, Daniel; WU ZHANG; GROSHEN, Susan et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3536-3544, issn 0732-183X, 9 p.Article

Low ERCC1 expression correlates with prolonged survival after cisplatin plus Gemcitabine chemotherapy in non-small cell lung cancerLORD, Reginald V. N; BRABENDER, Jan; SANCHEZ, José J et al.Clinical cancer research. 2002, Vol 8, Num 7, pp 2286-2291, issn 1078-0432Article

Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survivalBRABENDER, Jan; DANENBERG, Kathleen D; METZGER, Ralf et al.Clinical cancer research. 2001, Vol 7, Num 7, pp 1850-1855, issn 1078-0432Article

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapySHIROTA, Yoshinori; STOEHLMACHER, Jan; BRABENDER, Jan et al.Journal of clinical oncology. 2001, Vol 19, Num 23, pp 4298-4304, issn 0732-183XArticle

Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patientsKURAMOCHI, Hidekazu; TANAKA, Koji; DANENBERG, Peter V et al.International journal of oncology. 2008, Vol 32, Num 1, pp 201-208, issn 1019-6439, 8 p.Article

Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiationSCHNEIDER, Sylke; PARK, David J; DONGYUN YANG et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 8, pp 555-563, issn 1744-6872, 9 p.Article

Survivin, a potential biomarker in the development of barrett's adenocarcinoma. DiscussionVALLBÖHMER, Daniel; PETERS, Jeffrey H; DANENBERG, Peter et al.Surgery. 2005, Vol 138, Num 4, pp 701-707, issn 0039-6060, 7 p.Article

A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagusBRABENDER, Jan; MARJORAM, Paul; DANENBERG, Kathleen D et al.Oncogene (Basingstoke). 2004, Vol 23, Num 27, pp 4780-4788, issn 0950-9232, 9 p.Article

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancerROSELL, Rafael; SCAGLIOTTI, Giorgio; BONI, Corrado et al.Oncogene (Basingstoke). 2003, Vol 22, Num 23, pp 3548-3553, issn 0950-9232, 6 p.Article

Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. DiscussionLORD, Reginald V. N; JI MIN PARK; DANENBERG, Peter V et al.Journal of thoracic and cardiovascular surgery. 2003, Vol 125, Num 2, pp 246-253, issn 0022-5223, 8 p.Conference Paper

Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinomaKAWAKAMI, Kazuyuki; BRABENDER, Jan; SIDRANSKY, David et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 22, pp 1805-1811, issn 0027-8874Article

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal AdenocarcinomaLEICHMAN, Lawrence P; GOLDMAN, Bryan H; DANENBERG, Kathleen D et al.Journal of clinical oncology. 2011, Vol 29, Num 34, pp 4555-4560, issn 0732-183X, 6 p.Article

High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1KURAMOCHI, Hidekazu; HAYASHI, Kazuhiko; UCHIDA, Kazumi et al.Cancer chemotherapy and pharmacology. 2008, Vol 63, Num 1, pp 85-89, issn 0344-5704, 5 p.Article

5-Fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasisKURAMOCHI, Hidekazu; HAYASHI, Kazuhiko; UCHIDA, Kazumi et al.International journal of cancer. 2006, Vol 119, Num 3, pp 522-526, issn 0020-7136, 5 p.Article

Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagusVALLBÖHMER, Daniel; DEMEESTER, Steven R; PETERS, Jeffrey H et al.The American journal of gastroenterology. 2006, Vol 101, Num 7, pp 1458-1466, issn 0002-9270, 9 p.Article

Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancerKURAMOCHI, Hidekazu; HAYASHI, Kazuhiko; UCHIDA, Kazumi et al.Clinical cancer research. 2006, Vol 12, Num 1, pp 29-33, issn 1078-0432, 5 p.Article

Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancerSCHNEIDER, Sylke; YOCHIM, Jimin; BRABENDER, Jan et al.Clinical cancer research. 2004, Vol 10, Num 5, pp 1588-1596, issn 1078-0432, 9 p.Article

Association between cyclooxygenase expression and colorectal adenoma characteristicsEINSPAHR, Janine G; KROUSE, Robert S; JI MIN YOCHIM et al.Cancer research (Baltimore). 2003, Vol 63, Num 14, pp 3891-3893, issn 0008-5472, 3 p.Article

Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinomaBRABENDER, Jan; LORD, Reginald V; HÖLSCHER, Arnulf H et al.The Journal of surgical research. 2001, Vol 99, Num 2, pp 301-306, issn 0022-4804Article

Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequenceLORD, Reginald V. N; TSAI, Peter I; KIYABU, Milton et al.Surgery. 2001, Vol 129, Num 3, pp 267-276, issn 0039-6060Article

Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study)WU ZHANG; AZUMA, Mizutomo; HOLLYWOOD, Ellen et al.Anticancer research. 2010, Vol 30, Num 10, pp 4209-4217, issn 0250-7005, 9 p.Article

  • Page / 3